Post by Genentech

What happens when biotechnology meets AI? At BIO 2026, Genentech CEO Ashley Magargee joined NVIDIA's Kimberly Powell and moderator Katie Couric to discuss how AI is reshaping drug discovery and helping scientists move from trial-and-error approaches toward prediction-driven science. As Genentech marks 50 years of innovation, we're building on the same pioneering spirit that helped launch the biotech industry. By working with partners across science and technology, we're finding new ways to understand disease and help advance potential medicines for patients. Because behind every scientific breakthrough is a patient waiting for what comes next.